Search

Your search keyword '"Cancrini, Caterina"' showing total 558 results

Search Constraints

Start Over You searched for: Author "Cancrini, Caterina" Remove constraint Author: "Cancrini, Caterina"
558 results on '"Cancrini, Caterina"'

Search Results

2. A case of T-cell acute lymphoblastic leukemia in retroviral gene therapy for ADA-SCID

3. Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiency

4. Human germline heterozygous gain-of-function STAT6 variants cause severe allergic disease

6. Long term longitudinal follow-up of an AD-HIES cohort: the impact of early diagnosis and enrollment to IPINet centers on the natural history of Job’s syndrome

7. Activated phosphoinositide 3-kinase δ syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity

8. Immune tolerance breakdown in inborn errors of immunity: Paving the way to novel therapeutic approaches

9. The Impact of SARS-CoV-2 Infection in Patients with Inborn Errors of Immunity: the Experience of the Italian Primary Immunodeficiencies Network (IPINet)

10. Epstein–Barr virus‐associated smooth muscle tumor in a female with ataxia telangiectasia: A case report

11. Progressive Depletion of B and T Lymphocytes in Patients with Ataxia Telangiectasia: Results of the Italian Primary Immunodeficiency Network

12. Outcomes and Treatment Strategies for Autoimmunity and Hyperinflammation in Patients with RAG Deficiency

13. Neonatal Manifestations of Chronic Granulomatous Disease: MAS/HLH and Necrotizing Pneumonia as Unusual Phenotypes and Review of the Literature

14. Clinical, Immunological, and Molecular Variability of RAG Deficiency: A Retrospective Analysis of 22 RAG Patients

16. Use of dupilumab for atopic dermatitis in pediatric and young adult patients with inborn errors of immunity.

17. Mechanisms of genotype-phenotype correlation in autosomal dominant anhidrotic ectodermal dysplasia with immune deficiency

18. Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations

19. Vasculitis and vasculopathy associated with inborn errors of immunity: an overview

22. Corrigendum: Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56bright NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin Content

23. Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56bright NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin Content

24. Primary immunodeficiency diseases: Genomic approaches delineate heterogeneous Mendelian disorders

25. Characterization of T and B cell repertoire diversity in patients with RAG deficiency

26. Long-term follow-up of 168 patients with X-linked agammaglobulinemia reveals increased morbidity and mortality

27. Rituximab Unveils Hypogammaglobulinemia and Immunodeficiency in Children with Autoimmune Cytopenia

28. The Italian Registry for Primary Immunodeficiencies (Italian Primary Immunodeficiency Network; IPINet): Twenty Years of Experience (1999–2019)

29. Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency.

31. Urogenital Abnormalities in Adenosine Deaminase Deficiency

32. Immunophenotype Anomalies Predict the Development of Autoimmune Cytopenia in 22q11.2 Deletion Syndrome

33. X-linked agammaglobulinemia (XLA): Phenotype, diagnosis, and therapeutic challenges around the world

34. Gastric cancer, inflammatory bowel disease and polyautoimmunity in a 17-year-old boy: CTLA-4 deficiency successfully treated with Abatacept

35. A systematic analysis of recombination activity and genotype-phenotype correlation in human recombination-activating gene 1 deficiency

36. Risk of thyroid neoplasms in patients with 22q11.2 deletion and DiGeorge-like syndromes: an insight for follow-up

37. Efficacy and Adverse Events During Janus Kinase Inhibitor Treatment of SAVI Syndrome

39. Activated phosphoinositide 3-kinase δ syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity

40. Characteristics and Clinical Implications of Anti-IFN-α cytokine antibodies in partial Recombinase Activating Gene Deficiency patients before and during the COVID-19 Pandemic

41. The Wiskott-Aldrich syndrome protein is required for iNKT cell maturation and function

42. Hematopoietic stem cell gene therapy for the cure of blood diseases: primary immunodeficiencies

43. The case of an APDS patient: Defects in maturation and function and decreased in vitro anti-mycobacterial activity in the myeloid compartment

44. Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: A large patient cohort study

46. Activated Phosphoinositide 3-Kinase δ Syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity

49. Tailored treatments in inborn errors of immunity associated with atopy (IEIs-A) with skin involvement

50. How CD4+ T Cells Transcriptional Profile Is Affected by Culture Conditions: Towards the Design of Optimal In Vitro HIV Reactivation Assays

Catalog

Books, media, physical & digital resources